TickerFacts.

CytoDyn Inc. (CYDY): Long-Term Debt

Annual figures by period end, from SEC filings.

$38.34M
As of 2026-05-31
-5.7%
3-year compound annual growth
-10.0%
5-year compound annual growth
$64.75M2013-05-31: $1.48M2014-05-31: $2.34M2015-05-31: $43.5K2021-05-31: $64.75M2022-05-31: $42.22M2023-05-31: $45.73M2024-05-31: $45.02M2025-05-31: $45.35M2026-05-31: $38.34M$38.34M
2013-05-31 Long-Term Debt (USD) 2026-05-31
Period endedLong-Term DebtChange YoYSource filing
2026-05-31$38.34M-15.5%2026-08-31, Balance as of period end
2025-05-31$45.35M+0.7%2026-08-31, Balance as of period end
2024-05-31$45.02M-1.6%2025-07-25, Balance as of period end
2023-05-31$45.73M+8.3%2024-08-15, Balance as of period end
2022-05-31$42.22M-34.8%2023-09-14, Balance as of period end
2021-05-31$64.75Mn/a2022-08-15, Balance as of period end
No annual figure between 2015-05-31 and 2021-05-31.
2015-05-31$43.5K-98.1%2015-07-10, Balance as of period end
2014-05-31$2.34M+57.9%2015-07-10, Balance as of period end
2013-05-31$1.48Mn/a2014-07-10, Balance as of period end

Long-Term Debt at similar companies

Companies with the same SEC industry code (Pharmaceutical Preparations), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedLong-Term DebtChange YoY
CytoDyn Inc. (CYDY)2026-05-31$38.34M-15.5%
Clene Inc. (CLNN)2025-12-31$17.79Mn/a
Propanc Biopharma, Inc. (PPCB)2025-06-30$537.9K+34.7%
Jyong Biotech Ltd. (MENS)2025-12-31$2.12Mn/a
Emmaus Life Sciences, Inc. (EMMA)2025-12-31$27.13M-6.3%
Gain Therapeutics, Inc. (GANX)2025-12-31$401.0K-8.6%
HCW Biologics Inc. (HCWB)2025-12-31$0-100.0%
Elicio Therapeutics, Inc. (ELTX)2025-12-31$10.00Mn/a
CV Sciences, Inc. (CVSI)2025-12-31$1.65Mn/a

Compare CYDY, CLNN, PPCB, MENS side by side · Screen every company in Pharmaceutical Preparations ↗